A/Prof Thomas Rasmussen
Clinical (Associate Professor)
Department of Infectious Diseases
97 Scholarly works
8 Projects
HIGHLIGHTS
2026
Journal article
LBP-022-YI Single-dose of a novel monoclonal anti-HBV antibody (HepB mAb19) demonstrates sustained HBsAg suppression beyond 48 weeks: interim results from first-in-human phase I RUHBV1 and SAMBA trials
DOI: 10.1016/s0168-8278(26)00437-x2026
Journal article
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials
DOI: 10.1016/S2352-3018(25)00373-X2026
Journal article
The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study
DOI: 10.2147/CLEP.S5570202026
Journal article
Immunological dysfunction associated with SARS-CoV-2 persistence in immunocompromised patients
DOI: 10.1093/cei/uxag0222022
Research grants (other domestic)
Eliminating HIV That Persists on ART by Antogonising the Apoptosis Regulator, BCL-2
2021
Research grants (international)
Delaney AIDS Research Enterprise to Find a Cure (DARE 3.0) - (2021-2026) - SUBAWARD 7
2019
Research Contracts
Effects of Novel Peptides on Hiv Latency and Hiv-Specific T-Cell Function
RECENT SCHOLARLY WORKS
2025
Journal article
Pomalidomide enhances CD8 T and NK cell mediated killing of HIV-infected cells
DOI: 10.1016/j.ebiom.2025.1060042025
Journal article
Factors Influencing Virologic Control During Analytical Treatment Interruptions in HIV Cure Trials - a Pooled Analysis of Individual-Level Data
DOI: 10.1093/infdis/jiaf1632025
Journal article
Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025
DOI: 10.20411/pai.v10i2.8852025
Journal article
Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir
DOI: 10.1128/jvi.01676-242025
Journal article
Cardiometabolic Comorbidities in Patients With Chronic Hepatitis B and Impact on Incidence of Liver Complications. A Danish Nationwide Cohort Study.
DOI: 10.2147/IJGM.S4710832024
Journal article
7.1 – 00113 Safety and PD-1 receptor occupancy with low dose Nivolumab in adults living with HIV on antiretroviral therapy: NIVO-LD
DOI: 10.1016/j.jve.2024.100430
RECENT PROJECTS
2021
Research grants (international)
Delaney AIDS Research Enterprise to Find a Cure (DARE 3.0) - M&O - (2021-2026) - SUBAWARD 10
2021
Research Contracts
Safety, Immunogenicity and Efficacy of Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy (ART): NIVO-LD